In this episode, Josh bravely unpacks the stigma and fears he encountered during this transformative experience, shedding light on the profound impact it had on his well-being. As the FDA conducts groundbreaking research and approves psychedelics for mental health treatment, we explore the significance of these developments and what can be expected in the future. Additionally, we debunk prevalent myths associated with psychedelics, offering a more nuanced understanding of their therapeutic potential. Finally, Josh shares insights into PsycheX's mission of increasing access and education to reputable and legal psychedelic providers, with a special focus on supporting veterans. Tune in as we delve into the realm of mental health, psychedelics, and breaking down common myths surrounding their use.

guest: Josh Halu, the founder and CEO of PsycheX

About Psychex